Open Access
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML
DANIEL H. ALBERT, NEAL C. GOODWIN, ANGELA M. DAVIES, JENNY ROWE, GEROLD FEUER, MICHAEL BOYIADZIS, KATHLEEN A. DORRITIE, MARIA MANCINI, REGINA GANDOUR-EDWARDS, BRIAN A. JONAS, GAUTAM BORTHAKUR, IBRAHIM ALDOSS, DAVID A. RIZZIERI, OLATOYOSI ODENIKE, THOMAS PREBET, SANJANA SINGH, RELJA POPOVIC, YU SHEN, KEITH F. MCDANIEL, WARREN M. KATI, DIMPLE A. MODI, MONICA MOTWANI, JOHANNES E. WOLFF and DAVID J. FROST
In Vivo July 2022, 36 (4) 1615-1627; DOI: https://doi.org/10.21873/invivo.12872
